Buprenorphine pharmacokinetics: relative bioavailability of sublingual tablet and liquid formulations (Q41669477)

6 October 2017

title

Buprenorphine pharmacokinetics: relative bioavailability of sublingual tablet and liquid formulations (English)

1 reference

6 October 2017

1 reference

1 reference

Nath RP

1

1 reference

6 October 2017

Upton RA

2

1 reference

6 October 2017

Everhart ET

3

1 reference

6 October 2017

Cheung P

4

1 reference

6 October 2017

Shwonek P

5

1 reference

6 October 2017

Jones RT

6

1 reference

6 October 2017

Mendelson JE

7

1 reference

6 October 2017

publication date

1 June 1999

1 reference

The Journal of Clinical Pharmacology

6 October 2017

published in

1 reference

6 October 2017

volume

39

1 reference

6 October 2017

issue

6

1 reference

6 October 2017

page(s)

619-623

1 reference

Substitution pharmacotherapies for opioid addiction: from methadone to LAAM and buprenorphine

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008236

Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008236

Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008236

Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008236

A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008236

Effects of sublingually given naloxone in opioid-dependent human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008236

Effects of ethnicity on low-dose opiate stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008236

Sublingual absorption of selected opioid analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008236

Bioavailability of sublingual buprenorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008236

A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008236

Biliary excretion, metabolism and enterohepatic circulation of buprenorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008236

The systemic bioavailability of buprenorphine by various routes of administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008236

10.1177/00912709922008236

21 January 2018

Identifiers

DOI

1 reference

6 October 2017

1 reference